[Form 4] NOVANTA INC Insider Trading Activity

Rhea-AI Filing Summary

NOVANTA INC Chief Executive Officer Matthijs Glastra reported selling common stock in a pre-planned transaction. On May 12, 2026, he completed open-market sales totaling 7,500 shares at prices around $150–$151.34 per share under a pre-established Rule 10b5-1 trading plan.

Following these sales, he directly held 42,761 shares of Novanta common stock and indirectly held 54,382 shares through the Matthijs Glastra 2021 Irrevocable Trust. One sale at a weighted-average price of $151.34 was executed in multiple trades between $151.06 and $151.51.

Insights

Equity compensation and insider-trading analyst

CEO completes 7,500-share pre-planned sale while retaining sizable holdings.

The filing shows Matthijs Glastra, CEO of NOVANTA INC, conducted open-market sales of 7,500 shares on May 12, 2026. Trades occurred around $150–$151.34 per share, with one sale executed across multiple prices.

The footnotes state these sales were made under a pre-established Rule 10b5-1 trading plan adopted on September 11, 2025 through a trust where his spouse is a trustee. Such plans are arranged in advance, so timing carries less informational value about his current views.

After the transactions, Glastra held 42,761 shares directly and 54,382 shares indirectly via the Matthijs Glastra 2021 Irrevocable Trust. With no derivative positions listed, the visible exposure in this filing is entirely common stock, and the sales represent only part of his overall reported holdings.

Insider Trade Summary 10b5-1

Net Seller: 7,500 shares ($1,128,244)

Net Sell 3 txns

Insider Glastra Matthijs

Role Chief Executive Officer

Sold 7,500 shs ($1.13M)

Type	Security	Shares	Price	Value
Sale	Common Stock	5,079	$150.00	$762K
Sale	Common Stock	2,421	$151.34	$366K
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 45,182 shares (Direct, null); Common Stock — 54,382 shares (Indirect, Matthijs Glastra 2021 Irrevocable Trust)

Footnotes (1)

1. The sales reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan that was adopted on September 11, 2025 through a trust for which the reporting person's spouse is a trustee. This transaction was executed in multiple trades ranging from $151.06 to $151.51. The price reported above reflects the weighted-average price. The reporting person hereby undertakes to provide upon request from the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Glastra Matthijs

(Last) (First) (Middle)

C/O NOVANTA INC.

125 MIDDLESEX TURNPIKE

(Street)

BEDFORD MASSACHUSETTS 01730

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
NOVANTA INC [ NOVT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/12/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/12/2026		S(1)		5,079	D	$150	45,182	D
Common Stock	05/12/2026		S(1)		2,421	D	$151.34(2)	42,761	D
Common Stock								54,382	I	Matthijs Glastra 2021 Irrevocable Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sales reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan that was adopted on September 11, 2025 through a trust for which the reporting person's spouse is a trustee.

2. This transaction was executed in multiple trades ranging from $151.06 to $151.51. The price reported above reflects the weighted-average price. The reporting person hereby undertakes to provide upon request from the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Remarks:

Power of Attorney on file

	/s/ John Burke, Attorney-in-Fact	05/14/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)